SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-180111
Filing Date
2024-07-17
Accepted
2024-07-17 11:43:45
Documents
13
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d854625ddef14a.htm DEF 14A 160497
2 GRAPHIC g854625dsp56a.jpg GRAPHIC 3783
3 GRAPHIC g854625dsp56b.jpg GRAPHIC 2121
4 GRAPHIC g854625dsp56c.jpg GRAPHIC 2783
5 GRAPHIC g854625dsp56d.jpg GRAPHIC 3542
6 GRAPHIC g854625dsp56e.jpg GRAPHIC 3500
7 GRAPHIC g854625dsp56f.jpg GRAPHIC 3797
8 GRAPHIC g854625dsp56g.jpg GRAPHIC 3549
9 GRAPHIC g854625dsp56h.jpg GRAPHIC 3079
10 GRAPHIC g854625dsp57a.jpg GRAPHIC 803
11 GRAPHIC g854625dsp57b.jpg GRAPHIC 7818
12 GRAPHIC g854625dsp57c.jpg GRAPHIC 822
13 GRAPHIC g854625g0423115746058.jpg GRAPHIC 4429
  Complete submission text file 0001193125-24-180111.txt   218879
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32001 | Film No.: 241121452
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)